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Abstract
Background: Physical activity is a potentially effective treatment for depression and depressive relapse. However, promoting
physical activity in people with depression is challenging. Interventions informed by theory and evidence are therefore needed
to support people with depression to become more physically active. eMotion is a Web-based intervention combining behavioral
activation and physical activity promotion for people in the community with symptoms of depression.
Objective: The objectives were to assess the feasibility and acceptability of delivering eMotion to people in the community
with symptoms of depression and to explore outcomes.
Methods: Participants with elevated depressive symptoms were recruited from the community through various methods (eg,
social media) and randomized to eMotion or a waiting list control group for 8 weeks. eMotion is an administratively supported
weekly modular program that helps people use key behavior change techniques (eg, graded tasks, action planning, and
self-monitoring) to re-engage in routine, pleasurable, and necessary activities, with a focus on physical activities. Feasibility data
were collected that included the following: recruitment and trial retention rates; fidelity of intervention delivery, receipt, and
enactment; and acceptability of the intervention and data collection procedures. Data were collected for the primary (depression)
and secondary outcomes (eg, anxiety, physical activity, fidelity, and client satisfaction) at baseline and 2 months postrandomization
using self-reported Web-based questionnaires and accelerometers. Delivery fidelity (logins, modules accessed, time spent) was
tracked using Web usage statistics. Exploratory analyses were conducted on the primary and secondary outcomes.
Results: Of the 183 people who contacted the research team, 62 were recruited and randomized. The mean baseline score was
14.6 (SD 3.2) on the 8-item Patient Health Questionnaire depression scale (PHQ-8). Of those randomized, 52 participants provided
accelerometer-recorded physical activity data at baseline that showed a median of 35.8 (interquartile range [IQR] 0.0-98.6) minutes
of moderate-to-vigorous physical activity (MVPA) recorded in at least 10-minute bouts per week, with only 13% (7/52) people
achieving guideline levels (150 minutes of MVPA per week). In total, 81% (50/62) of participants provided follow-up data for
the primary outcome (PHQ-8), but only 39% (24/62) provided follow-up accelerometer data. Within the intervention group, the
median number of logins, modules accessed, and total minutes spent on eMotion was 3 (IQR 2.0-8.0), 3 (IQR 2.0-5.0), and 41.3
(IQR 18.9-90.4), respectively. Acceptability was mixed. Exploratory data analysis showed that PHQ-8 levels were lower for the
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intervention group than for the control group at 2 months postrandomization (adjusted mean difference −3.6, 95% CI −6.1 to
−1.1).
Conclusions: It was feasible to deliver eMotion in UK communities to inactive populations. eMotion has the potential to be
effective and is ready for testing in a full-scale trial. Further work is needed to improve engagement with both the intervention
and data collection procedures.
Trial Registration: ClinicalTrials.gov NCT03084055; https://clinicaltrials.gov/ct2/show/NCT03084055 (Archived by WebCite
at http://www.webcitation.org/6zoyM8UXa)
(J Med Internet Res 2018;20(7):e10112)   doi:10.2196/10112
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Introduction
Depression has a significant detrimental impact on individuals
and their families as well as being associated with increased
utilization of health services and reduced productivity at work.
In the UK, the cost to the economy due to sickness absence,
staff turnover, benefits, fall in tax revenue, and costs to the
National Health Service (NHS) is estimated to be between £74
billion and £99 billion per year [1]. Depression is also associated
with a range of major physical illnesses (which are also
associated with physical inactivity), including diabetes [2,3],
coronary heart disease [4], and obesity [5].
Physical activity (PA) has been shown to be effective in treating
[6-8] and preventing [9] depression and is often cited by patients
as their preferred treatment option [10,11]. A recent systematic
review of randomized controlled trials (RCTs) found PA to be
more effective than control conditions for reducing depression
(standardized mean difference [SMD] −0.62) and just as
effective as pharmacotherapy (SMD −0.11) and psychological
therapies (SMD −0.03) [6]. PA also has the potential to reduce
depressive relapses [12], improve anxiety symptoms [13], and
help prevent many physical health problems associated with
depression such as cardiovascular disease, cancer, and diabetes
[14]. Despite these benefits, PA is perceived as difficult to
prescribe compared with medication [15]. Further studies are
therefore needed to understand how and whether PA can be
cost-effectively used to improve outcomes for people with
depression, especially in those who are relatively inactive [16].
Behavioral activation (BA) is an evidenced-based psychological
therapy. BA focuses on reducing an individual’s exposure to
sources of negative reinforcement (ie, short-term relief from
avoiding burdensome activities) while increasing experiences
of positive reinforcement (ie, social and personal activities that
bring pleasure and achievement), leading to reduced avoidant
type-behaviors in the future [17-19]. A meta-analysis of 26
RCTs (n=1524) conducted on adults with depression found BA
to be superior to usual care, wait list, or placebo control
conditions (SMD −0.74) and medication (SMD −0.42) for
reducing depression [20]. The treatment rationale of BA shares
behavior change techniques (BCTs) [21] with interventions
promoting PA (eg, goal setting) [22]. By subtly shifting the
behavioral emphasis, the treatment rationale of BA could
therefore provide a useful delivery mechanism for promoting
PA in people with depression, capitalizing on the dual benefits
of PA and BA. Furthermore, sustained PA may reduce the
relapse rate associated with BA alone due to its inherent mood
enhancing and long-term benefits [12].
Recent studies have examined the feasibility of delivering a
combined BA and PA intervention (BAcPAc) within the context
of existing mental health services [22,23]. However, BAcPAc
was difficult to implement in overstretched services, it was hard
to recruit patients, and problems of fidelity were observed, with
providers not delivering the treatment as intended [23].
Web-based interventions could provide a useful way of
overcoming these limitations by delivering such interventions
outside of existing services, recruiting directly from the
community, and standardizing fidelity [24,25]. Furthermore,
Web-based interventions could have additional benefits by being
scalable, cheap, and accessible [26]. Importantly, Web-based
interventions can also be used to provide support to people
experiencing depression in UK communities who do not seek
help from health services due to social stigma and identity
conflict [27]. However, despite the potential benefits associated
with Web-based interventions, there remains a paucity of studies
that have attempted to deliver Web-based interventions
promoting PA for depression [28-31]. Furthermore, none of
these studies have explored the feasibly of delivering a
Web-based intervention combining BA and PA for people with
depression.
The purpose of the present study was to examine the feasibility
of delivering a Web-based intervention (eMotion), combining
PA with BA, for people with depression and to explore its effects
on depression and PA. The key aims of the study were to:
explore participant recruitment and attrition rates throughout
the study; explore the feasibility and acceptability of data
collection and study procedures; examine baseline characteristics
of the recruited sample, including levels of PA; explore the
fidelity of delivery, receipt, and enactment (use of techniques)
of eMotion and its acceptability to participants; and estimate
and explore the variance in key outcomes (depression scores
and PA).
Methods
Trial Design
Description of Trial Design
The eMotion trial was a 2-arm, individually randomized,
parallel-group pilot RCT with a nested process evaluation
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(ClinicalTrials.gov Identifier: NCT03084055). The study was
reported in accordance with Consolidated Standards of
Reporting Trials (CONSORT-EHEALTH) recommendations
for reporting of RCTs of eHealth interventions [32] and the
Template for Intervention Description and Replication (TIDieR)
recommendations on reporting of behavior change interventions
[33].
Important Changes to Methods After Trial
Commencement
The eMotion trial provided “minimal contact” administrative
support [34] at week 2 of the intervention to provide the
participant with a rationale for the use of self-help materials and
check-ins related to progress, but with no focus on any clinical
or behavior change issues. This support was initially intended
to be provided by an independent “supporter.” However, due
to resource issues, this support was provided by the lead author.
Participants
Eligibility Criteria for Participants
Participants were eligible for the study if they were more than
18 years old, were living in UK, had at least moderate depressive
symptoms [defined as scoring at least 10 on the 8-item Patient
Health Questionnaire depression scale (PHQ-8)], had access to
the internet and were computer literate, reported being able to
walk continuously and unaided for a minimum of 5 min, and
provided informed consent to participate. Eligible adults were
recruited from the community via advertisements in weekly
newspapers, social media (eg, Facebook support groups,
Twitter), and through banners on websites relating to mental
health problems. All adverts contained the primary investigator’s
contact details. Potential participants did not need to be referred
by a general practitioner or mental health care practitioner. After
contacting the lead author by phone or email, potential
participants were sent the participant information sheet (PIS),
consent form, and a link to the Web-based screening
questionnaire via email. At this point, they were informed that
they could withdraw from the study at any time without
consequence or being obliged to provide a reason. Once
participants read the PIS, they were asked to complete the
Web-based consent form (indicating consent using a checkbox)
followed by a screening questionnaire used by the lead author
to assess participant eligibility. After screening, the lead author
contacted the participant via phone to clarify the study
procedures and provide instructions for wearing the wrist-worn
accelerometers sent by post. The participant was instructed to
wear the accelerometer for 7 days and return it in a pre-stamped
addressed envelope. However, participant refusal to wear an
accelerometer did not preclude randomization. Further baseline
measures were then administered via a separate Web-based
questionnaire. Participants were not paid for their involvement
in the study.
The eMotion Intervention
The eMotion intervention is a Web-based course that provides
people with access to an evidence-based treatment based on BA
with added PA promotion. People with depression commonly
reduce activities that they perceive as burdensome, making less
effort to do things they may have previously enjoyed. By
avoiding such activities, people with depression experience
temporary relief that then negatively reinforces the likelihood
of avoiding further activities. However, avoiding such activities
has a long-term cost because it reduces the opportunities for
positive reinforcement that occurs when people engage in social
and personal activities that bring them pleasure and achievement
[17-19]. PA is often avoided by people with depression, but it
has the potential to provide additional anti-depressive benefits
as well as added health benefits.
Through a series of steps delivered in a week-by-week modular
fashion (Table 1), eMotion teaches people how to re-establish
daily routines, increasing activities that provide positive
reinforcement while reducing negative reinforcement. eMotion
comprises 13 modules (1 introduction module, 8 weekly
modules, 1 generic problem-solving module, and 3 unlockable
modules) consisting of visual content with an audio voiceover
triggered when each slide opens. Printable, interactive
worksheets, and emails were also included, with links to the
slides to allow downloading to a personal computer or another
device (eg, tablet or smartphone). Automated reminder emails
were also sent once a week by the eMotion program following
registration. Where possible, brief administrative/motivational
support via a 10-minute phone call was provided at week 2.
Key content related to the rationale of BA was front loaded in
the introduction, week 1, and week 2 and was considered the
“minimum dose.” The remaining weekly modules (weeks 3-8)
were shorter and designed to support people to review and
update their plans. The intervention supports “effective
engagement” and self-regulation by encouraging people to
review their plans weekly, irrespective of whether or not they
continue to login (eg, using their own diaries).
eMotion Development
The content for eMotion was developed by the study authors
(JDL, CJG, PF, AMH, and AHT). The Living Life to the Full
Web-based platform was used to host the intervention. eMotion
was adapted from the BAcPAc intervention [22,23] using the
Centre for eHealth Research and Disease Management
(CeHReS) roadmap [35]. The CeHReS roadmap is intended to
help the planning, coordination, and execution of the
participatory development process of eHealth. In eMotion, this
involved using patient and public involvement, usability testing,
and a structured literature search. A full description of the
eMotion intervention and its developmental process was
previously provided [36].
Control (Waiting List)
Participants in the control group did not receive the eMotion
intervention but were able to access usual care as normal. After
data collection at the 2-month time point, participants were
given access to and instructions for using eMotion. No eMotion
facilitator support was provided, although participants could
contact the lead researcher for (nonclinical) support if they
experienced any difficulties using the intervention.
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Table 1. eMotion structure.
Module in eMotionContentSteps
Introduction and Week 1People are provided with a full and comprehensive rationale for behavioral activation
and PAa, including reference to the interaction of physiological, behavioral, and
cognitive emotional symptoms, the role of avoidance in maintaining low mood and
the idea of routine, pleasurable, necessary, and activities (including PA).
Step 1: Provide a rationale
Weeks 2-8People are helped to identify routine, pleasurable, and necessary activities (including
PA)—things that they would like to do but have usually stopped doing since they
became depressed.
Step 2: Identify activities
Weeks 2-8People are helped to organize the activities into a hierarchy of difficulty—most
difficult, medium difficult, and easiest. People should include some of each type
of routine, pleasurable, and necessary activity (including PA).
Step 3: Make a hierarchy of activities
Weeks 2-8eMotion helps people to schedule some avoided activities into their week, to spec-
ify a mixture of routine, pleasurable, and necessary activities (including PA). These
should be initially identified from the “easiest” category of their hierarchy from
step 3). Activities should be detailed precisely: what, where, when, and with whom.
Step 4: Plan some activities
Weeks 2-8People are encouraged to undertake the planned activities. The principle of grading
activities and using a mixture of routine, pleasurable, and necessary activities (in-
cluding PA) should be followed. People should record if they accomplished the
planned activity.
Step 5: Implement activities
Weeks 3-8People are encouraged to reflect on their progress, congratulating themselves for
success and overcoming any problem-solving difficulties experienced during im-
plementation. People may make sporadic progress and activities may not go as
planned.
Step 6: Review progress
aPA: Physical activity.
Feasibility Outcomes
Recruitment and Attrition
Participant recruitment rates were derived by calculating the
absolute number of people randomized in the trial relative to
those who expressed an initial interest in the study. Participant
attrition was defined as the percentage of randomized
participants who began the intervention but failed to provide
primary outcome data (PHQ-8) at the 2-month data collection
point.
Feasibility of Data Collection
Feasibility of data collection was explored by assessing the
percentage of Web-based screening, baseline, and 2-month
postrandomization questionnaires that were completed, as
intended. For accelerometers, the percentage of devices that
were returned at baseline and at 2 months follow-up as well as
the amount of valid wear time were assessed. Reasons for any
missing data were tabulated, where available.
Primary Outcome for the Planned Future Trial
Depression
The PHQ-8 was delivered at screening and at 2 months
postrandomization using a Web-based self-completed version
of the questionnaire. The PHQ-8 is a freely available 8-item
self-report measure based on the symptoms of depression
described in the Diagnostic and Statistical Manual for Mental
Disorders (DSM-IV). It measures the frequency of depressive
symptoms over the preceding 2-week period. A score of at least
10 on the PHQ-8 has a positive likelihood ratio of 28 for
detecting major depression (ie, a patient with any depressive
disorder is 28 times more likely to have a PHQ-8 score of 10-24
than someone without a depressive disorder) [37]. Each item is
rated on a scale of 0-3, producing a range of scores from 0-24
(0-4=no depression, 5-9=mild depression, 10-14=moderate
depression, 15-19=moderately severe depression, and
20-24=severe depression). The PHQ-8 has good validity,
reliability, sensitivity, and specificity [37] and has been used in
previous Web-based intervention studies of low mood and
depression [38].
Secondary Outcomes for the Planned Future Trial
Objective Physical Activity
GENEActiv accelerometers (Activeinsights Ltd., Kimboloton,
Cambs, UK) were used to record PA at baseline and at 2-months
postrandomization. The GENEActiv is a small wrist-worn device
that measures and records acceleration. It was set to record at
100Hz. Data were downloaded using the GENEActiv PC
software (version 2.9) and processed in R
(https://cran.r-project.org/) using package GGIR (version 1.2-8)
[39,40]. Raw data were used to create a vector magnitude
√(x^2+ y^2+z^2)-1g negative numbers were rounded to 0 to
create the Euclidean Norm minus one (measured in mg), as
previously reported [41]. Data were averaged over 5-s epochs.
Nonwear was assessed over a 60-minute window, using moving
15-minute increments [42] if the standard deviation of 2 of the
3 axes were less than 13 mg and the value range was less than
50 mg. Participants were mailed the device before randomization
and instructed to wear it continuously on their nondominant
hand for 7 days from the following morning, without changing
their routine PA. To be considered valid for analysis, data were
needed for at least 4 days with a minimum of 10 h per day,
including at least 1 day on the weekend. Published thresholds
were used to determine average daily minutes of activity in light
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(LPA), moderate (MPA), vigorous (VPA), and moderate and
vigorous (MVPA) intensities [43]. Minutes of activity
accumulated in 10-minute bouts were established using an 80%
rule, where activity must be sustained above the appropriate
threshold for at least 80% of the time [42].
Self-Reported Physical Activity
Minutes per week of MVPA were estimated using Web-based
self-completion of the International PA Questionnaire-Short
Form (IPAQ-SF) at baseline and at 2-months postrandomization.
The IPAQ-SF is a validated measure of PA [44] and has been
used in previous behavioral trials promoting PA for depression
[29,45] as well as being the most frequently used measure in
Web-based studies for PA [46].
Anxiety
The General Anxiety Disorder scale (GAD-7) is a 7-item,
4-point scale (0-3) and was used to assess anxiety using
Web-based self-completion at baseline and at 2-months
postrandomization. The GAD-7 measures the severity of anxiety
symptoms over the past 2 weeks based on the DSM-IV criteria.
The GAD-7 has good reliability as well as criterion, construct,
factorial, and procedural validity. At the cutoff point of 10, the
GAD-7 has a sensitivity of 89% and specificity of 82% [37].
Demographic Data
Data on age, gender, level of education (GCSE, A-levels, degree,
postgraduate, or doctoral), employment status (full-time,
part-time, homemaker, student, retired, or unemployed), current
receipt of psychotherapy (yes or no), current receipt of
antidepressants (yes or no), method of recruitment (social media,
newspaper, word of mouth, or other), and ethnicity were
collected at baseline using a Web-based questionnaire.
Fidelity
As recommended in previous studies [25,47], intervention
fidelity was conceptualized and measured in the domains of
design fidelity, training fidelity, quality/completeness of
delivery, participant receipt, and enactment. The process of
establishing good design fidelity for the eMotion intervention
was previously reported [36]. However, given that the eMotion
intervention had very limited external human support, training
fidelity was not applicable in this study. Delivery fidelity was
assessed using website usage statistics from the Web-based
intervention database. This database provided individual level
data about whether the participant registered for eMotion,
modules accessed, and the total time spent on each module.
Participant receipt and enactment of the intended intervention
processes were measured using Web-based questionnaires. For
fidelity of receipt, 2 approaches were used. The first approach
assessed participants’ understanding of how emotions, behaviors,
thoughts, and physical feelings affect each other to maintain
depression over time. A single item was used based on questions
used in a previous study [48]. The item employed a 5-point
Likert response scale (Strongly Agree to Strongly Disagree)
assessing participant agreement with the following statement:
“I understand how emotions, behaviors, thoughts, and physical
feelings affect each other to maintain depression over time.”
The second approach assessed participants’ perceived ability
to use the intended BCTs. This was assessed by asking
participants to rate their confidence in using specific BCTs (ie,
identification of suitable activities, grading activities for ease
of use, and planning and dealing with setbacks) over the last 2
months on a scale from 1 (not at all confident) to 10 (very
confident). This measure was adapted from measures of
confidence used in the ProActive trial [49]. Finally, to assess
enactment, we asked participants if they had used specific BCTs
related to BA in the last 2 months using a binary scale (yes/no).
This measure was adapted from similar measures of BCT usage
showing that enactment was significantly associated with weight
loss, providing initial evidence of the validity of this type of
measure [50].
Acceptability
The Client Satisfaction Questionnaire-Short Form (CSQ-SF) is
a 4-item measure and was used to assess participant satisfaction
regarding their use of eMotion 2 months postrandomization
(given to intervention participants only). This measure was
administered using a Web-based questionnaire and has been
used to assess treatment satisfaction in other studies of
Web-based interventions for depression [51].
Sample Size
Due to the pilot nature of the study, no formal sample size
calculations were conducted. However, to ensure a suitably
reliable estimate of the standard deviations to power a future
trial with 90% power, at least 15 people per arm were
recommended if the expected effect size was to be between 0.3
and 0.7 [52]. A previous meta-analysis of computer-based
psychological treatments for depression reported a moderate
effect size (0.56) and a drop-out rate of 57% [38]. As such, a
target sample size of 62 was adopted (accounting for a possible
attrition rate of 50%) to ensure at least 15 people per arm at
follow-up.
Randomization
Once participants completed the baseline assessment, they were
randomly allocated to either the intervention or control group
using simple randomization at the individual level in a 1:1 ratio
and a Web-based randomization service (Sealed Envelope Ltd.
2016). Personal details were anonymized through the use of
participant numbers that were entered into the website by the
lead author in a consecutive manner (in the order of completed
baseline assessment), and the randomization service allocated
them to either group A (eMotion) or group B (waiting list)
without any stratification.
Blinding
Due to limited resources for the study, the lead author was not
blinded to which condition each participant was allocated
following randomization. Due to the nature of the intervention,
it was also impossible to blind participants to group allocation.
However, because outcome measures were taken using
Web-based self-report surveys, there was a reduced chance of
the lead author influencing the participant’s responses or for
the lead author to misinterpret responses or introduce subjective
bias into recorded observations [53].
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Statistical Analysis
Quantitative methods were used to explore the following:
recruitment and attrition rates of trial participants; feasibility of
data collection and study procedures; baseline data (including
levels of PA and baseline differences between groups and
between dropouts); and fidelity of delivery. Descriptive statistics
were produced for all outcomes by trial arm at baseline and
2-month follow-up. All quantitative analyses were conducted
using Stata SE statistical software release 14 (StataCorp. 2015;
College Station, TX). No formal hypothesis testing relating to
primary outcomes was planned because this was a pilot study.
However, descriptive statistics were used to assess recruitment
and retention rates and baseline PA levels. Baseline demographic
and clinical characteristics were descriptively presented as
proportions or as means with standard deviations. Two types
of exploratory analyses of the primary outcome (PHQ-8) were
conducted: 1) linear regression models to report changes in
depression with 95% confidence intervals around the
between-group mean difference and 2) logistic regression
models that dichotomized the primary outcome to reflect
clinically meaningful change (a reduction to below 10 on the
PHQ-8 indicated that the person may no longer qualify for major
depression) [37]. The analyses were conducted on participants
with complete data only, which included those who began
treatment and provided follow-up data regardless of treatment
compliance. Missing data were not imputed. Similar analyses
were conducted for anxiety, objective, and self-reported PA.
We conducted sensitivity analyses using linear regression
models to examine the effects of receiving psychological
therapies as well as any substantial differences in baseline
characteristics on the findings. We also analyzed the mean
reduction in depressive symptoms for those who received the
minimum dose of intervention and provided data at 2 months
postrandomization.
Ethics
This study was approved by the University of Exeter Sports and
Health Sciences Research Ethics Committee (AM160316-21
151021/B/03). One possible ethical issue in this study was
suicide risk in people experiencing depression. Because this
was a research study on a nonclinical sample, all participants
were advised on the PIS that the study was not a clinical or NHS
treatment and that the University and researchers could not take
clinical responsibility for the treatment of any conditions they
might have including depression. They were also signposted to
other appropriate resources in case they wished to seek formal
treatment. If, at any point in the study (eg, while on the phone
to a researcher during screening or after inclusion), participants
indicated suicidal intent, the University of Exeter Mood
Disorders Suicide Risk Protocol was invoked.
Results
Participant flow
A total of 183 people responded to the adverts, with 100
completing screening for eligibility (Figure 1). Of the 183
individuals who initially inquired about the study, 100 were still
interested and screened for eligibility and 62 (34% of those who
initially enquired [95% CI 27-41] and 62% (62/100) of those
who were screened [95% CI 52-71]) were eligible for inclusion
and randomized in the trial between May 2016 and February
2017 (32 in the eMotion group, 30 in the control group). Overall
attrition in relation with the planned main trial primary outcome
(PHQ-8) at 2 months postrandomization was 19% (12/62; 95%
CI 11-31). Of those randomized, 94% (58/62) of participants
provided complete secondary outcome baseline measurements
(eg, GAD7, IPAQ-SF) and 84% (52/62) provided usable
accelerometer data at baseline. At 2-month follow-up, 81%
(50/62) of those randomized [95% CI 71-91] provided PHQ-8
(and other survey data) and 39% (24/62) of those randomized
[95% CI 27-52] provided valid accelerometer data. Only 76%
(47/62) and 53% (33/62) participants provided valid IPAQ-SF
data at baseline and 2 months postrandomization, respectively.
This lack of usable IPAQ-SF data was due to people providing
invalid responses.
Feasibility of Accelerometer Data Collection
At baseline, 6 accelerometers were not sent out due to
participants not responding to the request confirming their
willingness to wear it or not being willing /able to wear it. Three
accelerometers had data processing problems (technical failure).
At follow-up, missing accelerometer data were primarily due
to participants not responding to the request to wear the device
again (n=13) or participants being lost to follow-up (not
responding in any way; n=9).
Baseline Demographic and Clinical Characteristics
At baseline (Table 2 and Table 3), the mean age was 38 years
with women accounting for 84% (52/62) of all participants, and
97% (60/62) of participants were white British. Nearly half the
sample was recruited through social media (Facebook or Twitter)
with the second most popular method being “word of mouth”
(ie, hearing about the study from friends or family). Participants
had a range of educational levels, and most (55/62, 89%) of
them were employed either part-time or full-time. The mean
score on the PHQ-8 was 14.6 (SD 3.2), and the mean score on
the GAD-7 was 11.8 (SD 4.5). All PA data were positively
skewed; hence, medians and interquartile ranges were reported.
The median daily total minutes of accelerometer-measured PA
was 174.3 (IQR 136.8-212.5) for light PA (LPA), 53.5 (IQR
39.8-80.7) for moderate PA (MPA), 2.9 (IQR 1.0-6.2) for
vigorous PA (VPA), and 55.2 (IQR 40.9-90.7) for moderate
and vigorous PA (MVPA). The median weekly total minutes
of accelerometer-measured MVPA in at least 10-minute bouts
was 35.8 (IQR 0.0-98.6). Only 13% (7/52) people achieved at
least 150 minutes per week of MVPA in at least 10-minute
bouts. The median level of daily self-reported MVPA was 12.9
minutes (IQR 0.0-25.7). Over half (36/62, 58%) of the
participants were receiving antidepressants, and 13% (8/62)
were receiving some form of psychotherapy, with a higher
proportion receiving therapy in the control group (7/30, 23%)
than in the intervention group (1/32, 3%). The intervention
group had a higher median of total MVPA per day (71 min,
IQR 46.7-85.9) than the control group (55 min, IQR 40.1-90.7).
Finally, the intervention group was older by 2 years with a mean
of 39.3 (12.0) years compared with 36.9 (12.6) years in the
control group.
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Figure 1. CONSORT flow chart.
Table 2. Participant demographic and clinical characteristics at baseline.
Whole sampleControl groupeMotionCharacteristics
Mean (SD)NMean (SD)NMean (SD)N
38.1 (12.3)6236.9 (12.6)3039.3 (12.0)32Age in years
14.6 (3.2)6214.8 (2.9)3014.4 (3.5)32Depression (PHQ-8a)
11.8 (4.5)5812.3 (4.2)2711.5 (4.7)31Anxiety (GAD-7b)
35.8 (0.0-98.6)5242.1 (8.1-93.7)2529.5 (0.0-98.8)27Min per week of objective MVPAc in 10-min boutsd
12.9 (0.0-25.7)4710.7 (3.6-17.9)2012.9 (0.0-25.7)27IPAQ-SF daily min of MVPAd
aPHQ-8: Patient Health Questionnaire 8.
bGAD-7: General Anxiety Disorder scale.
cMVPA: moderate-to-vigorous intensity physical activity.
dData were positively skewed, so medians (interquartile ranges) are reported.
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Table 3. Participant demographic and clinical characteristics at baseline.
Whole SampleControl GroupeMotionCharacteristics
n (%)Nn (%)Nn (%)N
52 (84)6226 (87)3026 (81)32Female
8 (13)627 (23)301 (3)32Receiving therapy
36 (58)6218 (60)3018 (56)32Antidepressants
7 (13)524 (16)253 (11)27>150 m per week of MVPAa (10-min bouts)
55 (89)6227 (90)3028 (88)32Currently employed, studying, or training
48 (77)6223 (77)3025 (78)32Educated to A level or beyond
aMVPA: moderate-to-vigorous intensity physical activity.
Intervention fidelity
In total, 88%(28/32) of the intervention participants registered
for eMotion and began the introduction module. The median
number of logins, modules accessed, and total minutes spent
on eMotion was 3 (IQR 2-8), 3 (IQR 2-5), and 41.3 (IQR
18.9-90.4), respectively. Overall, 53% (17/32) of participants
completed at least the introduction, week 1, and week 2, and
25% (8/32) of participants completed up to at least week 4. Only
one participant used every module. Of the 46 participants who
provided receipt and enactment data at both baseline and 2
months postrandomization, those randomized to the eMotion
group reported a significant difference, compared with the
control group, in levels of understanding about how thoughts,
feelings, and behaviors affect mood (adjusted mean difference
0.5, 95% CI −0.0 to −1.0). Significant differences were also
found for confidence to identify (adjusted mean difference 1.4,
95% CI 0.0-2.8), select (adjusted mean difference 1.3, 95% CI
−0.02 to 2.6), and plan (adjusted mean difference 1.8, 95% CI
0.5-3.1) achievable activities to improve mood as well as
confidence to deal with setbacks (adjusted mean difference 1.5,
95% CI 0.2-2.7). Of the participants who answered “no” on the
enactment questionnaires at baseline, those who were
randomized to the eMotion group were significantly more likely
to select (N=25; OR 10, 95% CI 1.6-62.7) and plan (N=33; OR
10.3, 95% CI 2.0-52.6) activities to improve their mood at the
2-month follow-up.
Acceptability
Of the participants randomized to receive the eMotion
intervention who provided follow-up data, 4% (1/25) felt almost
all their needs had been met, 32% (8/25) felt most of their needs
had been met, 52% (13/25) felt only a few of their needs had
been met, and 12% (3/25) felt none of their needs had been met.
Twenty-four percent (6/25) said they would definitely use the
program again, 32% (8/25) said “Yes I think so,” 40% (10/25)
said “No, I don’t think so,” and 4% (1/25) said “Definitely not.”
Finally, 16% (4/25) said they were “Very Satisfied,” 40%
(10/25) said they were “Mostly Satisfied,” 40% (10/25) said
they were “Indifferent or Mildly Satisfied,” and 4% (1/25) said
they were “Quite Dissatisfied.”
Exploratory Analysis of Outcomes
Exploratory analyses carried out on complete data (Table 4)
showed that at 2 months postrandomization, the intervention
group had a larger reduction in depressive symptoms than the
control group (adjusted mean difference −3.6, 95% CI −6.1 to
−1.1). In the intervention group, 56% (14/25) of depression
scores went below the threshold of 10 on the PHQ-8, compared
with 28% (7/25) in the control group (OR 3.3, 95% CI 1.0-10.6).
For those who completed the minimum dose of intervention
and provided data at 2 months postrandomization (n=15), the
mean reduction in depressive symptoms was 5 points (SD 5.4).
For those who did not complete the minimum dose of
intervention and provided data at 2 months postrandomization
(n=9), the mean reduction in depressive symptoms was 4.9
points (SD 4.6). Of the 47 participants who provided anxiety
scores at both baseline and 2 months postrandomization, there
was a larger reduction in symptoms of anxiety for the eMotion
group than the control group (adjusted mean difference −3.3,
95% CI −5.4 to −1.2). Linear regression analysis on complete
data, controlling for baseline PA, revealed no between-group
differences in PA at any intensity. Valid IPAQ-SF data were
available for 33 trial participants at 2 months postrandomization.
Linear regression analysis controlling for baseline PA revealed
no between-group differences in self-reported PA.
Sensitivity analysis
When receipt of other psychological therapies was entered into
the regression analysis as a covariate, the impact of co-treatment
was not significant, and the intervention group still had a higher
reduction in depressive symptoms than the control group
(adjusted mean difference −3.3, 95% CI −5.9 to −0.7). Other
baseline covariates (age, gender, employment, education level,
and antidepressant usage) that may have influenced depression
scores were also entered in the regression model together.
Findings indicated that none of these variables had a significant
covariate effect on depression scores and that the residual
difference between groups was still significant (adjusted mean
difference −3.1, 95% CI −5.7 to −0.5). Within the intervention
group, linear regression analyses revealed no significant
relationships between numbers of modules accessed, number
of logins, or total minutes spent on the website with depression
outcomes. The pattern of change scores within each group is
shown in Figure 2.
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Table 4. Between-group changes in primary and secondary outcomes.
Adjusted mean differencea (95% CI)Control groupeMotionOutcomes
Mean (SD)NMean (SD)N
Depression (PHQ-8b)
14.8 (2.9)3014.4 (3.4)32Baseline
−3.6 (−6.1 to −1.1)12.9 (4.2)258.7 (4.8)252 months postrandomization
Anxiety (GAD-7c)
12.0 (4.7)2710.1 (5.4)31Baseline
−3.3 (−5.4 to −1.2)10.9 (3.7)257.1 (3.8)252 months postrandomization
Min per week of objective MVPA in 10-min boutsd
42.1 (8.1 to 93.7)2529.5 (0.0 to 8.8)27Baseline
16.4 (−43.7 to 76.5)13.0 (0.0 to 131.4)1197.6 (49.7 to 166.3)132 months postrandomization
IPAQ-SF daily minutes of MVPAd
10.7 (3.6 to 17.9)2012.9 (0.0 to 25.7)27Baseline
0.2 (−8.7 to 9.2)15.7 (0.0 to 22.9)1411.4 (4.3 to 25.7)192 months postrandomization
aMultiple regression adjusted for baseline value and confidence intervals reported.
bPHQ-8: Patient Health Questionnaire 8.
cGAD-7: General Anxiety Disorder scale.
dAs physical activity data were skewed, medians and interquartile ranges (IQR) are presented, and analysis was repeated using bootstrapping.
Figure 2. PHQ-8 change scores for individual participants.
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Discussion
Summary of Findings
The present study examined the feasibility of conducting an
RCT of the eMotion intervention. We successfully recruited a
less-active population with elevated depression and anxiety.
The trial also had acceptable attrition rates concerning the
primary outcome at 2 months. Concerning the feasibility of data
collection, most people provided valid accelerometer data at
baseline. However, there was a lack of valid accelerometer data
at 2 months postrandomization. The baseline level of MVPA
in 10-minute bouts was low, with only 13% (7/52) of
participants achieving at least 150 minutes of MVPA per week.
Of those randomized to the intervention group, most people
registered for eMotion and just over half completed the
“minimum dose” (introduction, week 1, and week 2).
Exploratory analyses revealed larger changes in depressive
symptoms and anxiety in the eMotion group than those in the
control group at 2 months postrandomization. Descriptive PA
data revealed a higher weekly median of minutes of MVPA in
10-minute bouts per week in the eMotion group than in the
control group at 2 months postrandomization. This difference
was not significant, although this may reflect low numbers
available for analysis and high variance in this measure.
Relationship to Other Literature
The achieved recruitment rates resembled those found in other
studies of Web-based interventions promoting PA for depression
[29-31,45,54]. Other studies report between 26% and 46% of
people approached being subsequently randomized
[29-31,45,54]. Mailey et al [54] recruited students registered
with mental health counseling services but did not have an
inclusion criterion for the level of depressive symptoms, possibly
contributing to their higher recruitment rate (46%).
Our retention rate compared well with other self-delivered trials
of psychological and PA interventions for depression [30]. A
recent 3-arm RCT comparing administratively supported
Web-based BA, PA, and a waiting list control group had a
similar retention rate to ours at 8 weeks postrandomization
(82%) [30]. Conversely, a systematic review of Web-based
psychological treatments for depression reported drop-out rates
of 74% for unsupported, 38.4% for administratively supported,
and 28% for therapist-supported treatments [38]. Some
individual trials of Web-based PA interventions for depression
have reported lower attrition rates than ours (8%-12%) [29,54].
However, both of these trials provided therapist support, whereas
our study only provided administrative support. Our data,
combined with previous research, suggested that a low level of
administrative support may be adequate to retain acceptable
numbers of participants at follow-up.
Most studies investigating the effect of PA on depression
conceptualize PA as a prescribed structured intervention and
have not previously measured baseline levels or changes in PA
[6,8]. Also, change in PA has typically not been measured or
reported in trials of psychological treatments for depression
[55]. This is one of the few intervention studies to collect
baseline PA data (using objective measures) in people with
elevated depressive symptoms, building on other recent
intervention studies following a similar approach [56].
With a baseline median of 35.8 (IQR 0.0-98.6) minutes per
week of MVPA (in at least 10-minute bouts), we appear to have
recruited a less-active sample than other similar studies. For
example, a recent cross-sectional study (n=165) of adults with
depression (≥10 on the PHQ-9) reported a baseline mean of
18.2 (SD 17.4) minutes of MVPA (in 10-minute bouts) per day
[57]. One possible explanation for this is that the clear indication
of “exercise” in the PIS attracted people with depression who
were already active [57]. In eMotion, however, the intervention
was not overtly presented as exercise, but rather as a behavioral
intervention to promote routine, pleasurable, and necessary
activities (which could include PA).
The current guidelines for PA (150 minutes of MVPA per week)
are based on improving and maintaining physical health, rather
than mental health [58]. The dose of PA for improving and
maintaining mental health is not clear and may well be linked
to the quality of the experience rather than just the physical
volume. For example, a recent longitudinal cohort study
(n=33,908) suggests that 12% of future cases of depression
could be prevented with just 60 minutes of any intensity PA per
week [59].
Only 56% of the participants in the intervention arm accessed
at least the introduction, week 1, and week 2 (minimum dose),
suggesting that more could be done to draw potential users into
the website. eMotion actively encouraged participants to engage
with the process of BA in their day-to-day lives (eg, planning
and reviewing goals using their diaries). This was reflected in
our process measures of receipt and enactment showing that
despite the relatively low usage statistics, people randomized
to eMotion were more confident to identify, select, and plan
activities to improve their mood as well as to deal with setbacks
(ie, to engage in the key processes of behavior change proposed
by the eMotion logic model) [36]. This explanation is consistent
with a recent observational study (n=8993) of a Web-based
handwashing intervention (PRIMIT) [60]. In PRIMIT, the
largest change in behavior occurred after the first session, with
incrementally smaller changes occurring after each subsequent
session [60]. Taken together, these findings suggest that usage
metrics reveal little about offline engagement with intervention
processes and that usage cessation could either indicate
disengagement from the intervention or the development of
sufficient mastery [61].
Exploratory analysis revealed a decrease in symptoms of
depression and anxiety in favor of the intervention group at 2
months postrandomization, a similar reduction to that found in
previous studies promoting PA for depression [23,29-31,45]
and anxiety [13]. However, other studies did not find such an
effect [54,62,63], possibly due to low power and the use of
active control conditions [7]. Our findings tentatively support
the utility of using BA as a more-general treatment for
depression and anxiety and are consistent with findings from a
large-scale RCT that found BA to be no less effective than
cognitive behavioral therapy for treating depression [64].
However, it is important to note that due to its low power,
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definitive conclusions around effectiveness cannot be made
from the current study.
Strengths and Limitations
This is the first study to evaluate the feasibility of delivering
BA in combination with the explicit promotion of PA, in a
Web-based format. The main strength of this study was the use
of rigorous methods to assess the feasibility of conducting a
full-scale RCT. We used objective methods to assess PA and
validated self-report measures of depression and anxiety
symptoms. However, several limitations of this study need to
be acknowledged.
As observed in other large-scale depression trials, our sample
did not represent the wider UK population, particularly in terms
of ethnicity and gender [64,65]. This is most likely an artifact
of our recruitment method (ie, community recruitment) and
target location (South West England). However, there are other
individual factors including ability to recognize and accept
mental health problems, positive impact of social networks,
reluctance to discuss psychological distress and seek help among
men, cultural identity, perceived social stigma against mental
health, and financial factors [66]. A larger trial could attempt
to recruit a more representative sample by targeting locations
with more culturally diverse populations. Tailored recruitment
approaches could also be used to address individual barriers to
engagement (eg, using adverts targeted at males).
Although we randomized participants, due to a lack of resources
for independent data collection, there was no blinding, which
could have led to an inflation of the observed effects [67].
However, the potential for researcher bias was limited in this
case due to an absence of any face-to-face contact when
collecting outcome measures. Our groups were imbalanced at
baseline with regard to co-interventions. However, these factors
did not seem to strongly impact the findings. A future trial could
remedy this either by including therapy as a
randomization-minimization variable or adding it as an exclusion
criterion.
Due to resource issues, “minimal contact” administrative support
was provided by the lead author. It is possible that this may
have led to bias when collecting outcomes. However, because
the outcomes were collected via self-administered Web-based
questionnaires and accelerometers, this is unlikely to have had
an effect. We would still recommend using independent
supporters in the main trial for practical reasons and for testing
the feasibility of providing such support in a “real-world” NHS
context, if the intervention proves effective in a full-scale RCT.
A further limitation is that the PHQ-8 was used rather than the
more conventional PHQ-9. The PHQ-8 was chosen due to the
lack of any directly available clinical surveillance or support
for participants, as it would not have been feasible to follow-up
any (Web-based) survey responses expressing suicidal ideation
in response to PHQ item 9 with an immediate telephone
interview. The PHQ-8 is specifically recommended for use in
such circumstances [37]. Furthermore, the PHQ-8 is very similar
to the PHQ-9 and has excellent convergent validity (r=0.997),
indicating that the 2 scales are comparable [68].
Implications for Future Research
Future studies should refine procedures (as indicated above)
and further develop the eMotion intervention to optimize user
engagement and experiences. Despite exploratory data showing
modest reductions in depression and anxiety, only half of the
people who used eMotion were mostly or very satisfied with
their experience. Qualitative interviews performed on a sample
of participants (n=11) have helped to identify barriers and
facilitators to engaging with the intervention and with the trial
(including the use of accelerometers) and suggest ways to
maximize data collection and minimize attrition. This data will
be reported in detail elsewhere. Refinements of the study
procedures would also be needed to collect more complete and
meaningful data on PA in any future trial. This could be
achieved via face-to-face contact or by providing incentives.
In line with the MRC framework [69], large, well-controlled
RCTs that build on the findings from this pilot trial could help
to more definitively test whether such an intervention is effective
in reducing depression and increasing PA in
community-dwelling populations with depression in the UK
and elsewhere.
Conclusion
The eMotion intervention is novel in attempting to offer an
integrated solution to the 2 critical public health priorities of
depression and lack of PA. Based on the data presented, both
the eMotion intervention and methods needed to conduct a trial
seem to be feasible and acceptable. If successful in a large-scale
trial, eMotion would have the potential to reduce depression
and anxiety symptoms for people in the community, easing the
burden on NHS resources. There may also be further potential
to increase PA in this population.
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